item management s discussion and analysis of financial condition and results of operations cautionary statement under the private securities litigation reform act of statements in this annual report that are not historical facts constitute forward looking statements within the meaning of section a of the securities act of  as amended  and section e of the securities exchange act of  as amended 
any statements contained herein which are not historical facts or which contain the words anticipate  believe  continue  estimate  expect  intend  may  should and similar expressions are intended to identify forward looking statements 
such statements reflect the current view of the company with respect to future events and are subject to certain risks  uncertainties and assumptions  including  but not limited to  the risk that the company may not be able to implement its growth strategy in the intended manner including the integration of acquisitions  risks regarding currently unforeseen competitive pressures affecting participants in the healthcare market and risks affecting the company s industry  such as increased regulatory compliance and changes in regulatory compliance  changes in payor reimbursement levels and technological changes 
in addition  the company s business  operations and financial condition are subject to the risks  uncertainties and assumptions which are described in the company s reports and statements filed from time to time with the securities and exchange commission the sec 
for the year ended december  vs 
december  for the year ended december   revenues were  as compared to  for the year ended december   an increase of approximately  or 
this increase was primarily due to revenues associated with the operation of the beran facilities acquired in october revenues from such facilities increased by approximately  in fiscal as compared to fiscal and revenues associated with the company s physician management and consulting operations revenues from such operations increased by approximately  in fiscal as compared to fiscal  all of which were partially offset by the closure of the company s facility in secaucus  new jersey the secaucus facility in may revenues from such facility decreased by approximately  in fiscal as compared to fiscal and a decrease in revenues associated with facilities that were operated by the company for both of the years ended december  and revenues from such facilities decreased by approximately  in fiscal as compared to fiscal 
the same facility decline in revenues for the year ended december  is attributable  in part  to the new jersey automobile cost reduction act of which was implemented in the second quarter of fiscal this act allows for the pre certification of mri and other diagnostic imaging procedures reimbursable through automobile insurance carriers before each procedure is performed 
this requirement has caused some delays and decreases in mri and other diagnostic imaging referrals during the latter half of fiscal at various of the company s new jersey facilities 
for the year ended december   operating expenses were  as compared to  for the year ended december   an increase of approximately  or 
this increase was primarily due to i expenses incurred in connection with the operation of the beran facilities acquired in october expenses related to such facilities increased by approximately  in fiscal as compared to fiscal  ii increased expenses associated with facilities that were operated by the company for both of the years ended december  and expenses related to such facilities increased by approximately  in fiscal as compared to fiscal primarily due to increased salary expenses relating to new personnel  professional fees  temporary help costs and increased maintenance agreement costs relating to new equipment not covered by manufacturers warranties and iii expenses relating to the company s physician management and consulting operations expenses related to such operations increased by approximately  in fiscal as compared to fiscal 
the operating results for the company continue to be negatively impacted by the brooklyn facility 
for the years ended december  and  the brooklyn facility generated losses of  and  respectively 
the brooklyn facility continues to operate at a loss 
although the company continues to implement certain revenue enhancement measures  including excess capacity arrangements  there can be no assurance that the procedures generated at the brooklyn facility will be sufficient to better support the operations of the brooklyn facility 
for the year ended december  vs 
december  for the year ended december   revenues were  as compared to  for the year ended december   an increase of approximately  or 
this increase was primarily due to i revenues associated with the operation of the beran facilities acquired in october approximately  ii an increase in same facility revenue approximately  for facilities that were operated by the company for all of and  iii revenues associated with the operation of the new york city facility acquired in november approximately  and iv revenues associated with its physician management and consulting operations approximately  all of which were partially offset by x decreased revenues at the brooklyn facility approximately  and y the closure of the secaucus facility approximately 
for the year ended december   operating expenses were  as compared to  for the year ended december   an increase of approximately  or 
this increase was primarily due to i expenses incurred in connection with the operation of the beran facilities acquired in october approximately  ii increased expenses associated with facilities that were operated by the company for all of and approximately  relating to an increase in the number of procedures being performed  iii expenses incurred in connection with the operation of the new york city facility acquired in november approximately  iv expenses relating to its physician management and consulting operations approximately  all of which were partially offset by x the closure of the secaucus facility in may approximately  and y a decrease in non cash compensation charges in fiscal approximately  as compared to fiscal approximately 
the fiscal non cash compensation charges resulted from the grant of stock options to a a director of the company as consideration for his agreement  in his capacity as a partner in mr associates  to sell the brooklyn facility approximately  and b dfs  in its capacity as financial advisor  pursuant to a five year consulting agreement approximately  see liquidity and capital resources 
the operating results for the company were negatively impacted by the brooklyn facility  the philadelphia facility and the secaucus facility 
in connection with the company s review of the viability of the brooklyn facility  among other things  in september the company entered into a new lease arrangement with respect to the lease of this facility 
the company also continued its negotiations for the purchase of the limited partners interests in the philadelphia facility not currently owned by it ie  the limited partners interests and consummated such purchase in may in may  based upon losses already sustained and the expectation of continuing losses  the company decided to close the secaucus facility and sell the mobile mri unit it was using at such facility 
the sale enabled the company to substantially eliminate the overhead costs associated with the operations of the secaucus facility  including the related debt service 
during the year ended december   as a corporate general partner the company recorded  of losses attributable to the limited partnership interests in the philadelphia facility in excess of the limited partners capital accounts 
liquidity and capital resources of the company as of december   the company had a cash balance of  current assets of  and working capital of  the significant improvement in the company s working capital is a result of the company s renegotiation in september of the short term million dfs bridge loan into a long term liability 
as a result  the repayment date of the debt is now may   with principal and interest payments of approximately  payable by the company in each of the months commencing october  the outstanding balance of the dfs loan at the time of renegotiation was  the debt bears interest at per annum 
the dfs bridge loan was funded in october in connection with the beran acquisition and the initial repayment schedule was as follows no payment due in month one ie  november  interest only payments of  in each of months two through four ie  december  january and february  principal and interest payments of approximately  in each of months five and six ie  march and april with a balloon payment of  due in month seven ie  may  which balloon payment date had been subsequently extended to august  cash flows provided by operating activities were  for the year ended december   which consisted primarily of i net income of  ii depreciation and amortization of  and iii an increase in the allowance for doubtful accounts receivable of  other significant components of cash flows provided by operating activities include x an increase in deferred tax asset of  y an increase in accounts receivable of  and z an increase in goodwill of  all of which were partially offset by an increase in accounts payable and accrued expenses of  and a decrease in deferred transaction and financing costs of  cash flows used in investing activities were  which related to purchase of property  plant and equipment 
cash flows used in financing activities were  which consisted primarily of payments on capital lease obligations of  payments on the dfs bridge loan of  distributions to limited partners of  and payments on obligations related to subleased equipment of  all of which were partially offset by borrowings under the revolving line of credit of in december  the company agreed to guarantee a loan  from dfs to jihp the jihp loan 
this loan was funded by dfs to jihp on january  and bears interest at per annum and is repayable over months at  per month 
at december   approximately  of the loan was outstanding 
pma and each physician stockholder of pma have acknowledged that such extension of credit is for their benefit and have agreed that to the extent that the company is or becomes liable in respect of any indebtedness or other liability or obligation of either pma or jihp  and the acquisition by the company of of the outstanding capital stock of jihp is not consummated including any requisite stockholder approvals  then pma and each physician stockholder of pma agree to indemnify and hold the company harmless from and against any and all such liabilities and obligations 
effective december   the company entered into a loan and security agreement with dvi business credit corporation dvibc  an affiliate of dfs  to provide a revolving line of credit to the company 
the maximum amount available under such credit facility initially was  which amount increased to  in october in connection with the beran acquisition and further increased to  in december  with advances limited to of eligible accounts receivable  as determined by dvibc 
borrowings under the line of credit bear interest at the rate of over the prime lending rate and are repayable on may  the company s obligations under the credit facility are collateralized through a grant of a first security interest in all eligible accounts receivable 
the agreement contains customary affirmative and negative covenants including covenants requiring the company to maintain certain financial ratios and minimum levels of working capital 
borrowings under this credit facility are used to fund working capital needs as well as acquiring businesses which are complementary to the company 
at december  and  the company had  and  respectively  of borrowings under this credit facility 
prior to may   the philadelphia facility was operated as a joint venture among a wholly owned subsidiary of the company as the general partner holding a partnership interest and certain individual medical professionals and others as limited partners holding in the aggregate the remaining partnership interests 
effective may   the company s subsidiary consummated the purchase of the limited partners interest for  in cash 
at april   the net book value of this partnership interest was the  purchase price has been recorded by the company as goodwill and is being amortized over a period of years 
the company is currently negotiating the purchase of the limited partners ownership interests in the wayne facility 
this facility is operated as a joint venture among a wholly owned subsidiary of the company as the general partner holding a partnership interest and two individual medical professional  who also provide consulting services to this facility as limited partners holding in the aggregate the remaining partnership interest 
however  there can be no assurance that the company will be successful in its negotiations to acquire the limited partners ownership interest in the wayne facility 
in july  the company closed the williamstown facility 
the facility  historically and since its acquisition in october  had operated unprofitably 
following its acquisition  the company was unsuccessful in its attempts to profitably operate the facility 
it was decided that the company had to either invest in certain equipment upgrades to modernize the facility or cease its operations 
after analysis of the pertinent factors  the company determined to close the facility 
the closure of the williamstown facility resulted in a one time charge to operations during the quarter ended september  of approximately  which is primarily comprised of a reserve for estimated future cash outflows relating to the leased premises 
the nature of the company s operations require significant capital expenditures which generally have been financed through the issuance of debt and capital leases and proceeds received from the sale of equity securities  including the company s initial public offering of common stock and redeemable warrants in november  the subsequent exercise of such redeemable warrants and the sale of series c convertible preferred stock in february continued expansion of the company s business  including the expansion of the company s physician management consulting operations and clinical research operations  will require substantial cash resources and will have an impact on the company s liquidity 
the company believes that cash to be provided by the company s operating activities together with borrowings available from the company s revolving line of credit will enable the company to meet its anticipated cash requirements for its present operations for the next twelve months 
the company has instituted measures to improve its revenues  including the formation of atlantic imaging  the establishment of clinical research operations and the launching of clinicure 
com  and is also considering various other strategic alternatives  including additional joint ventures  the sale and or other disposition of all or a portion of its diagnostic imaging operations and expansion of its e commerce operations 
the company is also prepared to adopt additional expense reduction measures if its estimates as to its cash requirements and satisfaction thereof prove to be inaccurate 
continued expansion of the company s business  including the expansion of the company s physician management consulting operations and clinical research operations  will require additional sources of financing 
the company does not expect the adoption of recently issued accounting pronouncements to have a material effect  if any  on its financial condition or results of operations 
see note of the notes to the consolidated financial statements of the company and its subsidiaries 
item a 
quantitative and qualitative disclosures about market risk not applicable 

